Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection

Alyssa Schami1,2, M Nurul Islam3,4, Matthew Wall5,6

  • 1Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX, USA. ASchami@txbiomed.org.

Scientific Reports
|December 27, 2024
PubMed

Insights

Drug-resistant tuberculosis strains show altered cell envelope lipids, with increased phthiocerol dimycocerosates (PDIMs) relative to phosphatidyl-myo-inositol mannosides (PIMs). This lipid shift may influence Mycobacterium tuberculosis-host interactions and drug resistance.

Area of Science:

  • Microbiology
  • Biochemistry
  • Immunology

Background:

  • Drug-resistant (DR) Mycobacterium tuberculosis (M.tb) strains pose a significant public health threat.
  • The M.tb cell envelope is crucial for its survival but its lipid composition in relation to drug resistance is not well understood.

Purpose of the Study:

  • To investigate changes in peripheral cell envelope lipid levels in DR M.tb strains compared to drug-susceptible (DS) strains.
  • To explore the functional implications of these lipid alterations on M.tb-host interactions.

Main Methods:

  • Quantification of cell envelope lipids including phthiocerol dimycocerosates (PDIMs), phosphatidyl-myo-inositol mannosides (PIMs), lipomannan (LM), and mannose-capped lipoarabinomannan (ManLAM) in 22 M.tb strains with varying drug resistance profiles.
  • Analysis of ManLAM surface exposure.
  • Infection of human macrophages with DR and DS M.tb strains to assess bacterial association, uptake, and intracellular growth.

Main Results:

  • A higher ratio of PDIMs to PIMs was observed in DR M.tb strains, with unique PDIM isomers detected.
  • While overall LM and ManLAM levels were similar, ManLAM surface exposure increased with drug resistance.
  • DR M.tb strains showed reduced association with macrophages, and a pre-extensively drug-resistant (pre-XDR) strain exhibited decreased uptake but increased early intracellular growth.

Conclusions:

  • The PDIMs:PIMs ratio is a potential marker for M.tb drug resistance.
  • Increased hydrophobic cell envelope lipids, particularly PDIMs, may contribute to M.tb drug resistance and modulate host-pathogen interactions.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133